Literature DB >> 9585381

Seventeen-year-long follow-up of a family affected by type 2A multiple endocrine neoplasia (MEN 2A).

A Libroia1, U Verga, G Vecchi, F Banfi, F Zurleni, L Quadro, C Scurini, O Fattoruso, V Colantuoni.   

Abstract

This paper reports the results of a 17-year-long follow-up covering 17 members of a family affected by multiple endocrine neoplasia (MEN) type 2A, first diagnosed in 1980. This family is enrolled in our screening program. The thyroid, parathyroid and adrenal glands of the family members were investigated using the most sophisticated and sensitive techniques which have become available during this period, and their DNA was genetically tested for detecting RET mutations. Thanks to the combination of these two approaches it was possible to confirm the diagnosis in the members concerned from the genetic point of view, and to achieve an early diagnosis in the young members of the last generation before the clinical onset of the disease. The detection of a RET mutation also prompted a prophylactic thyroidectomy in a four year-old boy, in a pre-tumoral stage of the disease. Lastly, evidence is provided that genetic analysis of the DNA of the chorionic villi can be carried out as a prenatal test during routine amniocentesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585381     DOI: 10.1007/BF03350320

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

Review 1.  Investigation of phaeochromocytoma.

Authors:  P G Bouloux; M Fakeeh
Journal:  Clin Endocrinol (Oxf)       Date:  1995-12       Impact factor: 3.478

2.  A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.

Authors:  O Fattoruso; L Quadro; A Libroia; U Verga; G Lupoli; E Cascone; V Colantuoni
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

Review 3.  Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.

Authors:  R A DeLellis
Journal:  Lab Invest       Date:  1995-05       Impact factor: 5.662

4.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

Authors:  C Eng; D Clayton; I Schuffenecker; G Lenoir; G Cote; R F Gagel; H K van Amstel; C J Lips; I Nishisho; S I Takai; D J Marsh; B G Robinson; K Frank-Raue; F Raue; F Xue; W W Noll; C Romei; F Pacini; M Fink; B Niederle; J Zedenius; M Nordenskjöld; P Komminoth; G N Hendy; L M Mulligan
Journal:  JAMA       Date:  1996-11-20       Impact factor: 56.272

5.  Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases.

Authors:  S Casanova; M Rosenberg-Bourgin; D Farkas; C Calmettes; N Feingold; H M Heshmati; R Cohen; B Conte-Devolx; P J Guillausseau; C Houdent
Journal:  Clin Endocrinol (Oxf)       Date:  1993-05       Impact factor: 3.478

6.  Preliminary report of a kindred affected from MEN IIa.

Authors:  A Libroia; C Cremoncini; C Valente; F Silvestrini; B Palmieri; F Romani; F Zurleni; L Belli
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

7.  Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues.

Authors:  T Tsuzuki; M Takahashi; N Asai; T Iwashita; M Matsuyama; J Asai
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

8.  Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.

Authors:  S A Wells; D D Chi; K Toshima; L P Dehner; C M Coffin; S B Dowton; J L Ivanovich; M K DeBenedetti; W G Dilley; J F Moley
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

Review 9.  Management of individual tumor syndromes. Medullary thyroid carcinoma and hyperparathyroidism.

Authors:  K J Snow; A E Boyd
Journal:  Endocrinol Metab Clin North Am       Date:  1994-03       Impact factor: 4.741

10.  Characterization of the clinical features of five families with hereditary primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2.

Authors:  M F Robinson; E J Furst; V Nunziata; M L Brandi; J P Ferrer; M J Martins Bugalho; G di Giovanni; R J Smith; D T Donovan; B R Alford
Journal:  Henry Ford Hosp Med J       Date:  1992
View more
  2 in total

1.  Novel sequence variants of the genes associated with the multiple endocrine neoplasia syndromes 1 and 2. analysis by an "in silico approach.".

Authors:  P Igaz; A Patócs; K Rácz
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

2.  Clinical characteristics and genetic screening of an extended family with MEN2A.

Authors:  E Algün; N Abaci; M Kösem; C Kotan; B Köseoğlu; H Boztepe; R Sekeroğlu; H Aslan; C Topal; H Ayakta; I Uygan; F Alagöl; N Erginel-Unaltuna; H Aksoy
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.